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September 2016
RURAL ROCKS
RECALLS
 Recalled due to Burkholderia cepacia contamination
 Zecuity (sumatriptan) Migraine Patch - Temporarily
removed from market due to risk of burns and scars
SHORTAGES
 FDA Drug Shortages
DRUG
 First-time generic for Ziana
 New extended-release combo for type 2 diabetes
 Epclusa Approved for All Major HCV Genotypes
 Expanded GERD indication in pediatric patients ages 12
years and older
 New indication for uveitis
 FDA Drug Safety Communication: FDA warns about
serious risks and death when combining opioid pain or
cough medicines with benzodiazepines; requires its
strongest warning
 Medications Requiring Renal Dosage Adjustments
 220% increase in adverse reactions to zolpidem
 Could memory loss be reversed with a common
painkiller?
 DSN, Becton Dickinson team up to help educate
community pharmacies about injectable diabetes
treatments
 Codeine not safe for kids, AAP warns
 Levothyroxine for Hypothyroidism: Can Bedtime
Administration Be a Viable Option?
 Dexamethasone-based Mouthwash for Stomatitis
Prevention
 Notice of NDC Change from Arbor Pharmaceuticals, LLC
HOSPITAL
 5 Tips to Improve Your HCAHPS Scores
FDA
 Warnings updated due to disabling side effects
 WEN by Chaz Dean Cleansing Conditioners - under
investigation for adverse reactions
 Strengthened kidney warnings
 FDA Drug Approvals and Changes: August Edition
 FDA permits marketing of balloon device to treat
persistent Eustachian tube dysfunction
IMMUNIZATIONS
 Expanded immunization indication in adults 18-49 years
 National, Regional, State, and Selected Local Area
Vaccination Coverage among Adolescents Aged 13–17
Years — United States, 2015
 CDC Vaccine Price List
 CDC Provides Vaccine Recommendations for the 2016-
2017 Influenza Season
 CDC: New Vaccine Labels
INSURANCE
 4 Ways Pharmacists Can Be Superheroes for Medicare
Patients
NEWS
 CDC: Updated guidance for care of infants born to
mothers with possible Zika infection during pregnancy
(08/19/16)
 CDC: Valley Fever Awareness
 FDA Declares ‘General Wellness’ Devices Exempt From
Regulations
 DEA Announces Intent to Schedule Kratom - For
immediate release
 Drug Topic – Resource Center
 4 Things Pharmacists Should Know About Opioid-Induced
Constipation
 Video: How Pharmacists Can Help Prevent OIC
 Video: Steps Pharmacists Should Take to Reduce OIC
 NAN Alert – Observe for possible fluid leakage when
preparing parenteral syringes
 Splenda launches stevia sweetener
 PrescribeWellness partners with Independent Pharmacy
Alliance
 Many With Diabetes Missing Out on Statins
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 Zika Found in Eye Fluid in Study
 Teva Says Hoping to Launch EpiPen-Like Device by 2018
in U.S.
TOOLS AND RESOURCES
 CDC: Tools and Materials for Your Office
RECALLS
 Recalled due to Burkholderia cepacia contamination
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm511528.htm
Zecuity (sumatriptan) Migraine Patch - Temporarily removed from market due to risk of burns
and scars
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm504736.htm
SHORTAGES
 FDA Drug Shortages
o http://www.fda.gov/downloads/Drugs/DrugSafety/DrugShortages/UCM163172.xml
The drug shortage program, within the Center for Drug Evaluation and Research (CDER), addresses potential or actual shortages of prescription, over-the-
counter, or generic drugs that have a significant impact on public health.
Ammonium Chloride Injection (Updated - Currently in Shortage) Monday, September 19, 2016 1:00 PM
Atropine Sulfate Injection (Updated - Currently in Shortage) Monday, September 19, 2016 1:00 PM
Calcium Chloride Injection, USP (Updated - Currently in Shortage) Monday, September 19, 2016 1:00 PM
Calcium Gluconate Injection (Updated - Currently in Shortage) Monday, September 19, 2016 1:00 PM
Cefepime Injection (Updated - Currently in Shortage) Monday, September 19, 2016 1:00 PM
Dextrose Injection USP, 70% (Updated - Currently in Shortage) Monday, September 19, 2016 1:00 PM
Epinephrine Injection (Updated - Currently in Shortage) Monday, September 19, 2016 1:00 PM
Fentanyl Citrate (Sublimaze) Injection (Updated - Currently in Shortage) Monday, September 19, 2016 1:00 PM
Imipenem and Cilastatin for Injection, USP (Updated - Currently in Shortage) Monday, September 19, 2016 1:00 PM
Lidocaine Hydrochloride (Xylocaine) Injection (Updated - Currently in Shortage) Monday, September 19, 2016 1:00 PM
LifeCare PCA™ Sterile Empty Vial and Injector (Updated - Currently in Shortage) Monday, September 19, 2016 1:00 PM
Morphine Sulfate Injection, USP, CII, (Preservative-Free)(For PCA Use Only) (Updated - Currently in Shortage) Monday, September 19, 2016 1:00 PM
Multi-Vitamin Infusion (Adult and Pediatric) (Updated - Currently in Shortage) Monday, September 19, 2016 1:00 PM
Piperacillin and Tazobactam (Zosyn) Injection (Updated - Currently in Shortage) Monday, September 19, 2016 1:00 PM
Potassium Chloride Injection (Updated - Currently in Shortage) Monday, September 19, 2016 1:00 PM
Sodium Acetate Injection, USP (Updated - Currently in Shortage) Monday, September 19, 2016 1:00 PM
Sodium Bicarbonate Injection, USP (Updated - Currently in Shortage) Monday, September 19, 2016 1:00 PM
Sodium Chloride 0.9% Injection Bags (Updated - Currently in Shortage) Monday, September 19, 2016 1:00 PM
Sodium Chloride 23.4% Injection (Updated - Currently in Shortage) Monday, September 19, 2016 1:00 PM
Sufentanil Citrate (Sufenta) Injection (Updated - Currently in Shortage) Monday, September 19, 2016 1:00 PM
Tobramycin Injection (Updated - Currently in Shortage) Monday, September 19, 2016 1:00 PM
Vancomycin Hydrochloride for Injection, USP (Updated - Currently in Shortage) Monday, September 19, 2016 1:00 PM
Etoposide Phosphate (Etopophos) Injection (New - Currently in Shortage) Friday, September 16, 2016 1:00 PM
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Water-Miscible Vitamin A Palmitate (Aquasol A Parenteral) (New - Currently in Shortage) Friday, September 16, 2016 1:00 PM
Scopolamine (Transderm Scop) Transdermal System Patch (New - Currently in Shortage) Thursday, September 15, 2016 1:25 PM
Penicillin G Procaine Injection (Updated - Currently in Shortage) Friday, September 09, 2016 1:22 PM
Dexamethasone Sodium Phosphate Injection (Updated - Currently in Shortage) Thursday, September 08, 2016 1:15 PM
Leucovorin Calcium Lyophilized Powder for Injection (Updated - Currently in Shortage) Thursday, September 08, 2016 1:15 PM
Lidocaine Hydrochloride (Xylocaine) Injection (Updated - Currently in Shortage) Thursday, September 08, 2016 1:15 PM
Piperacillin and Tazobactam (Zosyn) Injection (Updated - Currently in Shortage) Thursday, September 08, 2016 1:15 PM
Potassium Chloride Injection (Updated - Currently in Shortage) Thursday, September 08, 2016 1:15 PM
Sodium Acetate Injection, USP (Updated - Currently in Shortage) Thursday, September 08, 2016 1:15 PM
Vancomycin Hydrochloride for Injection, USP (Updated - Currently in Shortage) Thursday, September 08, 2016 1:15 PM
Reserpine Tablets (Updated - Discontinuation) Tuesday, August 30, 2016 1:00 PM
Triamcinolone Hexacetonide Injectable Suspension (Aristospan) (Updated - Discontinuation) Tuesday, August 30, 2016 1:00 PM
Bleomycin Sulfate for Injection (Updated - Currently in Shortage) Monday, August 29, 2016 1:12 PM
Cefepime Injection (Updated - Currently in Shortage) Monday, August 29, 2016 1:12 PM
Leucovorin Calcium Lyophilized Powder for Injection (Updated - Currently in Shortage) Monday, August 29, 2016 1:12 PM
Piperacillin and Tazobactam (Zosyn) Injection (Updated - Currently in Shortage) Thursday, August 25, 2016 1:00 PM
Penicillin G Benzathine (Bicillin L-A) Injection (Updated - Currently in Shortage) Wednesday, August 24, 2016 1:30 PM
Penicillin G Procaine Injection (New - Currently in Shortage) Wednesday, August 24, 2016 1:30 PM
DRUG
 First-time generic for Ziana
https://online.epocrates.com/u/10a4565/clindamycin-tretinoin+topical
 New extended-release combo for type 2 diabetes
https://online.epocrates.com/u/10a7548/Jentadueto+XR
 Epclusa Approved for All Major HCV Genotypes
https://online.epocrates.com/u/10a7547/Epclusa
 Expanded GERD indication in pediatric patients ages 12 years and older
https://online.epocrates.com/u/10a4917/Dexilant
https://online.epocrates.com/u/10a7510/Dexilant+SoluTab
 New indication for uveitis
https://online.epocrates.com/u/10a3301/Humira
FDA Drug Safety Communication: FDA warns about serious risks and death when combining
opioid pain or cough medicines with benzodiazepines; requires its strongest warning
http://www.fda.gov/Drugs/DrugSafety/ucm518473.htm
 Medications Requiring Renal Dosage Adjustments
http://www.pharmacytimes.com/contributor/shivam-patel-pharmd-candidate/2016/08/medications-requiring-renal-dosage-
adjustments?utm_source=Informz&utm_medium=Pharmacy+Times&utm_campaign=PT%5FeNews%5FDaily%5FUnsponsored%5F8%2D19%2D16
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 220% increase in adverse reactions to zolpidem
http://www.univadis.com/viewarticle/220-increase-in-adverse-reactions-to-zolpidem-
441328?u=g7Nnk16ewgsJtuO1j0racp26fBgCcTuESKBOzIzYvrA95%2B5oYhgq6CU3D2hdiuQc&utm_source=newsletter%20email&utm_medium=email&utm
_campaign=ct-newsletter_wf-automated_fq-daily_cp-medicalupdates&utm_content=1043558&utm_term=automated_daily
 Could memory loss be reversed with a common painkiller?
o http://www.medicalnewstoday.com/articles/312262.php
DSN, Becton Dickinson team up to help educate community pharmacies about injectable
diabetes treatments
o http://www.drugstorenews.com/article/dsn-becton-dickinson-team-help-educate-community-pharmacies-about-injectable-diabetes-
treatm?tp=i-H55-Q5U-1ez-24sAx-1v-wGU-1c-Nua-24s54-
230zQ&utm_campaign=Daily&utm_source=Experian&utm_medium=email&cid=6385&mid=30714239
 Codeine not safe for kids, AAP warns
o http://www.managedhealthcareconnect.com/content/codeine-not-safe-kids-aap-warns
 Levothyroxine for Hypothyroidism: Can Bedtime Administration Be a Viable Option?
o http://www.consultant360.com/articles/levothyroxine-hypothyroidism-can-bedtime-administration-be-viable-option
 Dexamethasone-based Mouthwash for Stomatitis Prevention
o http://www.cancertherapyadvisor.com/breast-cancer/breast-cancer-dexamethasone-mouthwash-prevents-
stomatitis/article/522473/?DCMP=EMC-
CTA_Front&cpn=&hmSubId=&NID=&spMailingID=15437943&spUserID=NDgyNTEwMTE5NjYS1&spJobID=861227646&spReportId=OD
YxMjI3NjQ2S0
 Notice of NDC Change from Arbor Pharmaceuticals, LLC
Product
Description
Strength Size Form Old NDC
(Continue to
order until your
DC is depleted
of stock)*
NEW NDC
(Only Available
when the Old
NDC is depleted
at the DC)*
EVEKEO® CII
(amphetamine sulfate)
Tablets
5mg
5mg 100 count bottles Tablets 24338-0020-10 24338-0022-10
EVEKEO® CII
(amphetamine sulfate)
Tablets
10mg
10mg 100 count bottles Tablets 24338-0021-10 24338-0026-10
*IMPORTANT ORDERING INFORMATION:
There may still be available stock of the Old NDC at your distribution center, even though, it may indicate the Old NDC is "Discontinued by the Manufacturer".
"Discontinued by Manufacturer" does not necessarily mean the product is not available to order at your distribution center.
In addition, you may see that the New NDC has "0 Available". This means there is still stock available of the Old NDC at your distribution center to order for
your patients.
There is no change in pricing with this action
PP-EVE-US-0327
HOSPITAL
 5 Tips to Improve Your HCAHPS Scores
http://healthitanalytics.com/resources/white-papers/5-tips-to-improve-your-hcahps-
scores?elqTrackId=f2c6634e9c8a411792b599122e89f010&elq=481ccd6ac5624ac0ac538e4049a1ba85&elqaid=809&elqat=1&elqCampaignId=710
FDA
 Warnings updated due to disabling side effects
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm513065.htm
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 WEN by Chaz Dean Cleansing Conditioners - under investigation for adverse reactions
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm511890.htm
 Strengthened kidney warnings
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm506554.htm
 FDA Drug Approvals and Changes: August Edition
http://reference.medscape.com/features/slideshow/drug-review/2016/august?src=wnl_drugupdt_160822_mscpref&uac=4045DY&impID=1181825&faf=1
 FDA permits marketing of balloon device to treat persistent Eustachian tube dysfunction
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/UCM521063?source=govdelivery&utm_medium=email&utm_source=govdelivery
IMMUNIZATIONS
 Expanded immunization indication in adults 18-49 years
https://online.epocrates.com/u/10a5672/Prevnar+13
Chickenpox Vaccine: Your Best Protection
http://www.cdc.gov/features/preventchickenpox/index.html
What are the Reasons to Vaccinate My Baby?
o http://www.cdc.gov/features/reasonstovaccinate/index.html
National, Regional, State, and Selected Local Area Vaccination Coverage among Adolescents
Aged 13–17 Years — United States, 2015
o http://www.cdc.gov/mmwr/volumes/65/wr/mm6533a4.htm
 CDC Vaccine Price List
o http://www.cdc.gov/vaccines/programs/vfc/awardees/vaccine-management/price-list/index.html
 CDC Provides Vaccine Recommendations for the 2016-2017 Influenza Season
o http://www.medscape.com/viewarticle/868665?src=wnl_specrep_160918_mscpedit&uac=4045DY&impID=1198490&faf=1
 CDC: New Vaccine Labels
https://content.govdelivery.com/accounts/USCDC/bulletins/15eb28b
INSURANCE
 4 Ways Pharmacists Can Be Superheroes for Medicare Patients
o http://www.pharmacytimes.com/news/4-ways-pharmacists-can-be-superheroes-for-medicare-
patients?utm_source=Informz&utm_medium=Pharmacy+Times&utm_campaign=PT%5FeNews%5FDaily%5FUnsponsored%5F8%2D19
%2D16
NEWS
CDC: Updated guidance for care of infants born to mothers with possible Zika infection during
pregnancy (08/19/16)
http://echo4.bluehornet.com/hostedemail/email.htm?CID=35959271192&ch=28C78D77543DA38E236504C34EB2ED35&h=b18a40afb5a0becc04904f3238
b98be7&ei=T1dSfZYNO&schema=echo4
 CDC: Valley Fever Awareness
http://www.cdc.gov/features/valleyfever/index.html
 FDA Declares ‘General Wellness’ Devices Exempt From Regulations
o http://www.raps.org/Regulatory-Focus/News/2016/07/28/25463/FDA-Says-%E2%80%98General-Wellness%E2%80%99-Devices-
Exempt-From-Regulations/
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 DEA Announces Intent to Schedule Kratom - For immediate release
Contact DEA Public Affairs (202) 307-7977
Washington, DC – The Drug Enforcement Administration (DEA) today announced its intention to place the active materials in the kratom plant into
Schedule I of the Controlled Substances Act in order to avoid an imminent hazard to public safety. Mitragynine and 7-hydroxymitragynine are found in
kratom, which is a tropical tree indigenous to Thailand, Malaysia, Myanmar, and other areas of Southeast Asia. The announcement was made in the U.S.
Federal Register and can be found here.
Kratom is abused for its ability to produce opioid-like effects and is often marketed as a legal alternative to controlled substances. Law enforcement
nationwide has seized more kratom in the first half of 2016 than any previous year and easily accounts for millions of dosages intended for the
recreational market, according to DEA findings. In addition, kratom has a high potential for abuse, has no currently accepted medical use in treatment in
the United States, and has a lack of accepted safety for use under medical supervision. These three factors constitute a Schedule I controlled substance
according to the Controlled Substances Act passed by Congress in 1970.
Kratom has been seized by law enforcement in various forms, including powder, plant, capsules, tablets, liquids, gum/resin, and drug patch. Because the
identity, purity levels, and quantity of these substances are uncertain and inconsistent, they pose significant adverse health risks to users.
From February 2014 to July 2016, over 55,000 kilograms of kratom material were encountered by law enforcement at various ports of entry within the
United States. Additionally, another 57,000+ kilograms of kratom material offered for import into the United States between 2014 and 2016 are awaiting
an FDA admissibility decision. Together, this material is enough to produce over 12 million doses of kratom. The FDA has also warned the public not to use
any products labeled as containing kratom due to concerns about toxicity and potential health impacts. In addition, FDA has issued and updated two
import alerts related to kratom products. Kratom has been on DEA’s list of drugs and chemicals of concern for several years.
The American Association of Poison Control Centers identified two exposures to kratom from 2000 and 2005. Between 2010 and 2015, U.S. poison
centers received 660 calls related to kratom exposure. The Center for Disease Control (CDC) found that kratom abuse leads to agitation, irritability,
tachycardia, nausea, drowsiness, and hypertension. Health risks found in kratom abusers include hepatotoxicity, psychosis, seizure, weight loss, insomnia,
tachycardia, vomiting, poor concentration, hallucinations, and death. DEA is aware of 15 kratom-related deaths between 2014 and 2016.
 Drug Topic – Resource Center
o http://drugtopics.modernmedicine.com/tag/generics?cfcache=true&GUID=4E10CEE7-7762-4945-BD54-
02AD876BC4C3&rememberme=1&ts=12092016
 4 Things Pharmacists Should Know About Opioid-Induced Constipation
o http://www.pharmacytimes.com/conferences/painweek-2016/4-things-pharmacists-should-know-about-opioid-induced-
constipation?utm_source=Informz&utm_medium=Pharmacy+Times&utm_campaign=PT%5FPAIN%5FWEEK%5FConference%5FDay%5
F2%5F9%2D8%2D16
Video: How Pharmacists Can Help Prevent OIC
o http://www.pharmacytimes.com/conferences/painweek-2016/how-pharmacists-can-help-prevent-
oic?utm_source=Informz&utm_medium=Pharmacy+Times&utm_campaign=PT%5FPAIN%5FWEEK%5FConference%5FDay%5F2%5F9%
2D8%2D16
Video: Steps Pharmacists Should Take to Reduce OIC
o http://www.pharmacytimes.com/conferences/painweek-2016/steps-pharmacists-should-take-to-reduce-
oic?utm_source=Informz&utm_medium=Pharmacy+Times&utm_campaign=PT%5FPAIN%5FWEEK%5FConference%5FDay%5F2%5F9%
2D8%2D16
 NAN Alert – Observe for possible fluid leakage when preparing parenteral syringes
o http://www.ismp.org/NAN/files/NAN-20160915.pdf
 Splenda launches stevia sweetener
o http://www.drugstorenews.com/article/splenda-launches-stevia-sweetener?tp=i-H55-Q5U-1ez-24sAx-1v-wGU-1c-Nuq-24s54-
6bK49&utm_campaign=Daily&utm_source=Experian&utm_medium=email&cid=6385&mid=30714239
 PrescribeWellness partners with Independent Pharmacy Alliance
o http://www.drugstorenews.com/article/prescribewellness-partners-independent-pharmacy-alliance?tp=i-H55-Q5U-1ez-24sAx-1v-
wGU-1c-Nuf-24s54-5OoKm&utm_campaign=Daily&utm_source=Experian&utm_medium=email&cid=6385&mid=30714239
 Many With Diabetes Missing Out on Statins
o https://medlineplus.gov/news/fullstory_160908.html
 Zika Found in Eye Fluid in Study
o https://medlineplus.gov/news/fullstory_160986.html
 Teva Says Hoping to Launch EpiPen-Like Device by 2018 in U.S.
o http://www.managedhealthcareconnect.com/content/teva-says-hoping-launch-epipen-device-2018-us
TOOLS AND RESOURCES
 CDC: Tools and Materials for Your Office
o http://www.cdc.gov/hpv/hcp/tools-materials.html
